TrialCirculation. Heart failure2025

Proteomic Analysis of Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Clinical Trial.

Constantin-Cristian Topriceanu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.